Frequent measurement of blood flow changes could improve the ability of health care providers to diagnose and treat patients with vascular conditions, such as those associated with diabetes and high blood pressure.
A U.S.-Chinese team that included researchers from the National Institute of Biomedical Imaging and Bioengineering(NIBIB) and the National Heart, Lung, and Blood Institute, both parts of the National Institutes of Health, conducted a pilot study showing that an ultrathin, skin-conforming sensor—resembling a peel-away tattoo—provides non-invasive, precise, and continuous monitoring of circulation, including blood flow within the smallest vessels.
In a study published in the Oct. 30, 2015 issue of Science Advances, the researchers showed that the sensor can measure blood flow in both large and micro-sized blood vessels near the skin’s surface. They also provided details about the design and operation of the device. The researchers assessed the sensor’s performance under various conditions, showing that the technology could be used for continuous blood-flow monitoring during daily activities and in a variety of clinical research and health care settings.
In addition to diabetes and chronic hypertension, conditions that affect the health of blood vessels and surrounding tissue include kidney disease, autoimmune and other inflammatory conditions, the effects of aging and smoking, and a class of cholesterol-related abnormalities called dyslipidemias. Continuous monitoring of variations in blood flow could also be valuable in assessing these conditions in clinical and research scenarios.
The pilot-tested device, which was co-developed with researchers at Northwestern University, is among a variety of tools available to measure blood flow. Other devices, such as ones based on optical or acoustic methods, however, do not work as well when the body is in motion, and thus require a patient or study subject to remain still.
The researchers overcame these challenges with the soft, skin-conforming electronic device that is applied directly onto the skin and uses thermal sensors to collect data on changes in temperature, including those caused by changes in blood flow. The device can also apply a small amount of heat in order to test a subject’s responses. In this mode, a miniature pad in the device generates a heat impulse, while 14 surrounding thermal sensors detect the resulting heat flux. The signal is sent to a computer that calculates the velocity of blood flow occurring within two millimeters of the skin surface.
In their study, the researchers placed the sensor on a study subject’s forearm, over a large, visible vein, and then applied pressure for 60 seconds at various positions near the vein. Each time, the device sensed corresponding reductions in blood flow. The researchers also used a thermal camera that measures infrared signals to confirm that the blood-flow sensor measurements were accurate, even when the subject moved around.
Next, they chose a placement on the forearm that was not near a large vein, so that the device would detect blood flow in micro-sized blood vessels within the underlying tissue. The researchers were able to detect changes in blood flow when the study subject took a deep breath. Members of the team at a collaborating institution performed a separate test that involved delivering a gentle slap to the skin near the electronic sensor, which caused a mild reddening reaction. The sensor registered the skin reaction as an increase of surface temperature, accompanied by a change in the direction of blood flow within two millimeters of the skin’s surface.
According to co-author Alexander Gorbach, Ph.D., head of NIBIB’s Infrared Imaging and Thermometry Unit, the tests performed with the thermal sensor helped to establish a number of guidelines for its use, such as optimal placement of the sensor, and how deeply under the skin’s surface the device can assess blood flow. At this stage, the device shows promise as a low-cost, readily-fabricated sensor for use in ambulatory or hospital-based settings. Because of the link between chronic hypertension and some types of vascular diseases, the new sensor may be a useful addition to studies of hypertension and its consequences.
The Latest on: Vascular disease monitoring
via Google News
The Latest on: Vascular disease monitoring
- Anticoagulants Market: Rise in Prevalence of Cardiovascular and Kidney Diseases to Drive Marketon October 9, 2020 at 1:53 am
Anticoagulants prevent clot formation or enlargement of existing clots in the arteries or veins. Heparins, including unfractionated heparin (UFH) and low molecular weight heparin (LMWH); vitamin K ...
- Butterfly Network and American College of Cardiology Join Forces to Transform Cardiovascular Care with Ultrasoundon October 8, 2020 at 4:36 am
PRNewswire/ -- Butterfly Network and the (ACC) are joining forces to transform the use of ultrasound within cardiology using the Butterfly ...
- Increasing Prevalence of Chronic Diseases Set to Propel Growth in Remote Patient Monitoring Devices Market: TMRon October 7, 2020 at 7:43 am
From 2020 to 2030, the global remote patient monitoring devices market will record a stellar growth rate of about 12.5%, compounded annually. It will add notably to market worth. It is pertinent to ...
- United States Cardiovascular Devices Market Growth, Trends and Forecasts Report 2020-2025 - ResearchAndMarkets.comon October 7, 2020 at 6:01 am
Growth, Trends and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. The United States Cardiovascular Devices Market is expected to register a CAGR of 4.8% during ...
- As We Fight The Coronavirus Pandemic, We Cannot Ignore Non-Communicable Diseaseson October 6, 2020 at 3:13 pm
As the world’s attention stays riveted on the coronavirus pandemic, non-communicable diseases (NCDs) are silently wreaking havoc. Millions of people with NCDs are struggling to get the care they need ...
- Cardiovascular Screenings Fall as Telehealth Moves Inon October 5, 2020 at 9:14 am
Primary care visits declined dramatically after the COVID-19 public health emergency started and screenings for common cardiovascular risk factors fell sharply, cross-sectional data showed. Despite a ...
- FARXIGA Granted Breakthrough Therapy Designation in US for Chronic Kidney Diseaseon October 2, 2020 at 7:42 am
AstraZeneca’s FARXIGA® (dapagliflozin) has been granted Breakthrough Therapy Designation (BTD) in the US for patients with chronic kidney disease (CKD), with and without type 2 diabetes (T2D).
- Noncommunicable diseases leading cause of death in Jordan — surveyon September 30, 2020 at 5:00 pm
All countries can use STEPs information not only for monitoring NCDs and their risk factors within ... Moreover, those currently suffering from cardiovascular diseases (CVDs) or at high risk to ...
- Biotricity Accelerates Shift to Remote Monitoring with Bioflux® Direct Programon September 29, 2020 at 6:12 am
(GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced the launch of its Bioflux® Direct Program. The new offering ships ...
- Using heart to beat cardiovascular diseaseson September 28, 2020 at 6:21 pm
World Heart Day By Dr. Mohan Jayatilake Consultant Cardiologist (A former President of Sri Lanka Heart Association) Cardiovascular diseases (CVD) including strokes cause nearly half of all ...
via Bing News